OUR TEAM

Dr. Lindsay Caithness has over 20 years of experience in the pharmaceutical industry gained predominantly in client-facing technical, project management and commercial disciplines at Contract Development Manufacturing Organizations.

Lindsay started her career in validation at a start-up cytotoxin manufacturing facility, Dabur Oncology, which was later sold to Fresenius Kabi. While in leadership roles of increasing responsibility at Fisher Clinical, Aptuit, Catalent and Avara, she supported clients from small and large biopharma companies with their global development, clinical and commercial supply needs. Lindsay also has experience from a Client perspective, through her time leading the outsourcing of clinical supplies for GlaxoSmithKline.

Throughout her career, Lindsay has delivered site divestment, acquisition and integration programs, including participating in company sale processes. In her VP Sales role at TriRx, Lindsay works together with all site functions and the Executive Team, applying her industry knowledge to deliver for our clients. Lindsay has a BSc in Biochemistry from The University of St Andrews, UK, and a PhD in Molecular Toxicology and Pharmacology from The University of Surrey, UK.